this post was submitted on 26 Mar 2024
103 points (95.6% liked)

Technology

60052 readers
3048 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 2 years ago
MODERATORS
top 5 comments
sorted by: hot top controversial new old
[–] [email protected] 57 points 9 months ago (1 children)

A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk's Neuralink before allowing the brain implant company to test its device in humans.

That is a very, very good question.

[–] [email protected] 29 points 9 months ago (1 children)

I think John Oliver has covered this one. In particular, how poorly the FDA handles food safety but discusses inadequate funding and bureaucratic inefficiencies as a whole.

[–] [email protected] 6 points 9 months ago

You're not wrong in any way, they definitely do need more funding. No matter how much you throw at it, the enormity of the task of making sure everything that wants to come to market is safe for humans.. I can't imagine how humans can even keep up.

Sure, the risks associated with brain implants are high, but it's something you (hopefully) very consciously have to agree to. It's more value to test some artificial sweetener to make sure it doesn't give us diabetes.

[–] [email protected] 4 points 9 months ago (1 children)

Wouldn't be surprised if they used the 510k loophole.

[–] [email protected] 4 points 9 months ago

No fucking way. It's a PMA device. The rub is that M. it stands for market. As in clinical trials have a lower threshold.